Literature DB >> 8230020

Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury.

L S Lohmander1, L A Hoerrner, L Dahlberg, H Roos, S Björnsson, M W Lark.   

Abstract

OBJECTIVE: To determine in a cross sectional study the concentrations of stromelysin, tissue inhibitor of metalloproteinases (TIMP), and proteoglycan fragments in knee synovial fluid (SF) at different times after injury to cruciate ligament or meniscus.
METHODS: Joint fluid samples were obtained from patients with knee injury diagnosed by arthroscopy. Concentrations of stromelysin-1 and TIMP-1 were determined by immunoassay with monoclonal and polyclonal antibodies. Cartilage proteoglycan fragments were quantified by immunoassay with polyclonal antibodies or by dye precipitation.
RESULTS: Average concentrations of stromelysin increased 40-fold in association with injury, and after about 6 months decreased to a plateau level about 10-fold increased compared to a reference group with healthy knees. TIMP and proteoglycan levels also increased in similar temporal patterns, but less markedly. Increased average SF levels of these markers were maintained for at least 17 years after injury. SF from knees with injury contained a 1.5 to 2.5 molar excess of stromelysin over TIMP, while reference joint fluids contained a 2-fold molar excess of TIMP over stromelysin.
CONCLUSION: The persistent changes in SF markers after joint injury may be associated with the cartilage destruction and frequent development of posttraumatic osteoarthritis in this group of patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230020

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  24 in total

1.  MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.

Authors:  I Tchetverikov; L S Lohmander; N Verzijl; T W J Huizinga; J M TeKoppele; R Hanemaaijer; J DeGroot
Journal:  Ann Rheum Dis       Date:  2005-05       Impact factor: 19.103

2.  Increased concentrations of bone sialoprotein in joint fluid after knee injury.

Authors:  L S Lohmander; T Saxne; D Heinegård
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

Review 3.  Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease.

Authors:  L S Lohmander
Journal:  J Anat       Date:  1994-06       Impact factor: 2.610

4.  Delayed Gadolinium-Enhanced MR Imaging of Cartilage (dGEMRIC) following ACL injury.

Authors:  B C Fleming; H L Oksendahl; W A Mehan; R Portnoy; P D Fadale; M J Hulstyn; M E Bowers; J T Machan; G A Tung
Journal:  Osteoarthritis Cartilage       Date:  2010-02-11       Impact factor: 6.576

5.  Emerging ideas: prevention of posttraumatic arthritis through interleukin-1 and tumor necrosis factor-alpha inhibition.

Authors:  J Todd R Lawrence; James Birmingham; Alison P Toth
Journal:  Clin Orthop Relat Res       Date:  2010-12-16       Impact factor: 4.176

Review 6.  New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options.

Authors:  Martin K Lotz; Virginia B Kraus
Journal:  Arthritis Res Ther       Date:  2010-06-28       Impact factor: 5.156

7.  Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis.

Authors:  L S Lohmander; T Saxne; D K Heinegård
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

8.  Impact testing to determine the mechanical properties of articular cartilage in isolation and on bone.

Authors:  Leanne V Burgin; Richard M Aspden
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

9.  Resolution-dependent influences of compressed sensing in quantitative T2 mapping of articular cartilage.

Authors:  Nian Wang; Farid Badar; Yang Xia
Journal:  NMR Biomed       Date:  2020-02-10       Impact factor: 4.044

10.  Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study.

Authors:  Staffan Larsson; L Stefan Lohmander; André Struglics
Journal:  Arthritis Res Ther       Date:  2009-06-22       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.